The main findings in the present study are as follows: (1) schizophrenia patients treated with olanzapine or clozapine (both MetS and non-MetS groups) had significantly higher plasma levels of IL-6, IL-10, and TNF-α compared to normal controls. This evidence concerns the gene IL6 and metabolic syndrome.